Literature DB >> 16179661

A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease.

Anjan Chatterjee1, Karen E Anderson, Carol B Moskowitz, Willard A Hauser, Karen S Marder.   

Abstract

The natural history of psychiatric syndromes associated with Huntington's disease (HD) remains unclear, and longitudinal studies of symptoms such as depression, apathy, and irritability are required to better understand the progression and role of these syndromes and their effect on disability. Self-administered scales such as the Beck Depression Inventory (BDI) may be useful to document changes in symptoms over time, but the validity of self-report may be questionable with the inevitable progression of cognitive deficits. An alternative to the patient's self-report would be assessments by the caregiver. The authors assessed interrater agreement between patient self-assessment and caregiver assessment of patients status for the presence of depressed mood using the BDI and apathy and irritability using an apathy and irritability scale. Agreement between these scales across strata of cognitive status was also examined. Interrater agreement varied from moderate to good for the BDI, depending on patient cognitive status. Agreement for the apathy scores was low for patients with poor cognition and fair in patients with better cognition. Irritability scale agreement was fair at best and was the worst in patients with the most intact cognition. Caregiver assessment of patients' moods and apathy may be an acceptable alternative to patient self-report as patients' cognitive status worsens.

Entities:  

Mesh:

Year:  2005        PMID: 16179661     DOI: 10.1176/jnp.17.3.378

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  24 in total

1.  "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Chiachi Wang; Julie C Stout; Christopher A Ross; Elizabeth Aylward; Noelle E Carlozzi; Sarah Queller
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

2.  Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.

Authors:  Eric A Epping; Ji-In Kim; David Craufurd; Thomas M Brashers-Krug; Karen E Anderson; Elizabeth McCusker; Jolene Luther; Jeffrey D Long; Jane S Paulsen
Journal:  Am J Psychiatry       Date:  2015-10-16       Impact factor: 18.112

3.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

Review 4.  Depression and adherence to treatment in diabetic children and adolescents: a systematic review and meta-analysis of observational studies.

Authors:  Chuenjid Kongkaew; Katechan Jampachaisri; Chollapat A Chaturongkul; C Norman Scholfield
Journal:  Eur J Pediatr       Date:  2014-02       Impact factor: 3.183

5.  Resting-State Functional Connectivity in Patients with Long-Term Remission of Cushing's Disease.

Authors:  Steven J A van der Werff; J Nienke Pannekoek; Cornelie D Andela; Onno C Meijer; Mark A van Buchem; Serge A R B Rombouts; Roos C van der Mast; Nienke R Biermasz; Alberto M Pereira; Nic J A van der Wee
Journal:  Neuropsychopharmacology       Date:  2015-02-05       Impact factor: 7.853

6.  Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?

Authors:  N E Carlozzi; S Schilling; A L Kratz; J S Paulsen; S Frank; J C Stout
Journal:  Qual Life Res       Date:  2018-06-16       Impact factor: 4.147

7.  Irritability in pre-clinical Huntington's disease.

Authors:  Stefan Klöppel; Cynthia M Stonnington; Predrag Petrovic; Dean Mobbs; Oliver Tüscher; David Craufurd; Sarah J Tabrizi; Richard S J Frackowiak
Journal:  Neuropsychologia       Date:  2009-10-28       Impact factor: 3.139

Review 8.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

9.  The Brief Irritability Test (BITe): a measure of irritability for use among men and women.

Authors:  Susan Holtzman; Brian P O'Connor; Paula C Barata; Donna E Stewart
Journal:  Assessment       Date:  2014-05-15

10.  Psychometric properties and responsiveness of Neuro-QoL Cognitive Function in persons with Huntington disease (HD).

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Jane S Paulsen; Nancy R Downing; Rebecca Ready; Joel S Perlmutter; David Cella; Kelvin L Chou; Michael K McCormack; Stacey Barton; Jin-Shei Lai
Journal:  Qual Life Res       Date:  2019-12-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.